On 15 May 2017 Alexander Vinokurov quit his position as president of A1 (the investment arm of Alfa-Group) to develop his own investment company, Marathon Group, as managing partner and president.
"I am extremely grateful to Mikhail Fridman, German Khan, and Alexey Kuzmichev for the invaluable experience of working in one of the world's most successful business groups. My sincere wishes for success to the new A1 president, Andrey Tyasto, an experienced leader and supreme professional who became my friend during the time we worked together," Alexander Vinokurov said.
LLC "Marathon Group", which will operate under Marathon Group brand, was registered on 1 February 2017. The company's core business is investment in pharmaceutical, infrastructure, and agricultural projects and subsequent development of those assets.
The holding's shareholders are Alexander Vinokurov and Sergey Zakharov, who until now was A1 executive director. In the Marathon Group, Sergey Zakharov will hold the position of managing partner and chairman of the board.
On 16 May 2017, at the Adam Smith Institute's Russian Pharmaceutical Forum, Marathon Group will present its sub-holding, Marathon Pharma, which will be the parent of SIA Group (formerly SIA International), OJSC "Sintez", CJSC "Biocom", LLC "Mega Pharm" (the Da Zdorov and A-Mega pharmacy chain operator), and hold a participatory interest in LLC "Bentus Laboratories" (Sanitelle brand products). The sub-holding's Chief Operations Officer is Igor Krylov.
"Everywhere I have worked, I managed to create strong professional teams capable of solving the most challenging tasks. Each member of the Marathon Group team is the best in their field. They are people with impeccable professional reputations who have already proved themselves capable together of doing what to many seemed impossible. I am proud they accepted the offer to work in the Marathon Group, and am confident their collective expertise and experience will lead the company to success," Alexander Vinokurov said.